Common respiratory virus: EU Commission authorises mRNA vaccine
The EU Commission has authorised the mRNA vaccine ‘mResvia’, to immunise adults over 60 years of age against lower respiratory tract disease, which is caused by respiratory syncytial virus (RSV) infection.